Global Syringes and Cannulas Market Size By Type (Syringes, Cannulas), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Syringes and Cannulas Market was valued at USD 15.6 billion in 2023 and is projected to surpass USD 26.4 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. The market is experiencing robust growth due to the increasing prevalence of chronic and infectious diseases, a growing aging population, and rising demand for minimally invasive surgical procedures. Syringes and cannulas are critical components in drug administration, blood transfusions, vaccination drives, and fluid delivery systems, positioning them as essential tools in modern healthcare infrastructure.

Drivers:

1. Rising Incidence of Chronic Diseases:

The surging global burden of diabetes, cancer, and cardiovascular diseases is fueling the demand for safe and efficient injectable devices such as syringes and cannulas, both in hospitals and homecare settings.

2. Growth in Immunization Programs:

Government and non-government initiatives promoting mass vaccination against diseases like influenza, hepatitis, and COVID-19 are accelerating syringe demand worldwide.

3. Advancements in Cannula Design:

Technological innovations have led to the development of safety-engineered and disposable cannulas that reduce the risk of infections and needle-stick injuries, encouraging adoption in both developed and developing markets.

Restraints:

1. Environmental Impact of Disposable Medical Devices:

The increasing use of disposable syringes and cannulas contributes significantly to biomedical waste, raising concerns about sustainable waste management and regulatory compliance.

2. Supply Chain Disruptions:

Geopolitical conflicts and pandemic-related disruptions have strained the global supply chain for essential medical equipment, causing fluctuating availability and pricing volatility for syringes and cannulas.

Opportunity:

1. Increasing Demand from Home Healthcare:

The rising popularity of self-administered medication, such as insulin and hormone therapies, is boosting the need for user-friendly, safe syringes and cannulas designed for at-home use.

2. Expansion into Emerging Markets:

Rapid improvements in healthcare infrastructure across regions like Asia-Pacific, Latin America, and the Middle East present untapped growth potential for syringe and cannula manufacturers.

Market by System Type Insights:

The syringes segment dominated the market in 2023, accounting for the largest revenue share. Among syringes, disposable syringes are the most widely used due to their cost-effectiveness and infection control properties. The cannulas segment, particularly IV cannulas, is expected to witness substantial growth due to their expanding application in intravenous therapies, surgeries, and trauma care.

Market by End-use Insights:

In terms of end-use, hospitals & clinics held the majority share in 2023 due to the high patient inflow and widespread use of syringes and cannulas for various treatments. However, the homecare segment is anticipated to register the fastest CAGR, driven by growing patient preference for at-home treatments and rising geriatric populations.

Market by Regional Insights:

North America led the global syringes and cannulas market in 2023, owing to advanced healthcare infrastructure, high healthcare expenditure, and well-established regulatory frameworks. Asia-Pacific is forecast to witness the highest growth rate during the forecast period, supported by increasing healthcare investments, rising awareness, and growing prevalence of chronic diseases in countries like India and China.

Competitive Scenario:

Key players in the Global Syringes and Cannulas Market include Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Smiths Medical, Cardinal Health, Medtronic plc, EXELINT International, and Retractable Technologies, Inc. These companies are focusing on innovations such as auto-disable syringes, smart cannulas, and sustainability initiatives to gain competitive advantages.

Scope of Work – Global Syringes and Cannulas Market

Report Metric Details

Market Size (2023) USD 15.6 billion

Projected Market Size (2031) USD 26.4 billion

CAGR (2023–2031) 6.9%

Market Segments By System Type (Syringes, Cannulas); By End-use (Hospitals & Clinics, Homecare, Others); By Region

Growth Drivers Rising chronic disease prevalence, expansion of immunization programs, innovations in cannula design

Opportunities Homecare device demand, emerging market penetration

Key Market Developments:

In 2023, Becton, Dickinson and Company launched an eco-friendly line of low-waste syringes aimed at improving sustainability in hospitals and clinics.

In 2024, Terumo Corporation announced the development of next-gen safety cannulas featuring reduced pain points and anti-contamination technology.

In 2025, Nipro Corporation expanded its production capacity in India to meet growing demand across Asia-Pacific and Africa.

Smiths Medical, in collaboration with a tech start-up, began testing IoT-enabled smart syringes for better dose monitoring and inventory control.

FAQs:

1) What is the current market size of the Global Syringes and Cannulas Market?

The market size was valued at USD 15.6 billion in 2023.

2) What is the major growth driver of the Global Syringes and Cannulas Market?

The major growth driver is the increasing prevalence of chronic diseases and rising demand for immunization and minimally invasive treatments.

3) Which is the largest region during the forecast period in the Global Syringes and Cannulas Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to grow the fastest during the forecast period.

4) Which segment accounted for the largest market share in the Global Syringes and Cannulas Market?

The syringes segment, particularly disposable syringes, accounted for the largest market share.

5) Who are the key market players in the Global Syringes and Cannulas Market?

Key players include Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Smiths Medical, and Cardinal Health.